CEL-SCI logo

CVM - CEL-SCI News Story

$6.17 0.5  9.4%

Last Trade - 9:10pm

Sector
Healthcare
Size
Small Cap
Market Cap £179.9m
Enterprise Value £159.0m
Revenue £n/a
Position in Universe 4546th / 7405

BRIEF-Cel-Sci To Develop Leaps COVID-19 Immunotherapy In Collaboration With University Of Georgia Center For Vaccines And Immunology

Mon 23rd March, 2020 2:55pm
March 23 (Reuters) - CEL-SCI Corp  CVM.A :
    * CEL-SCI TO DEVELOP LEAPS COVID-19 IMMUNOTHERAPY IN
COLLABORATION
WITH UNIVERSITY OF GEORGIA CENTER FOR VACCINES AND IMMUNOLOGY

Source text for Eikon:  urn:newsml:reuters.com:*:nBw9J4bP2a
Further company coverage:  CVM.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.